Thiel Carsten
EVP, Chief Commercial Officer at ALEXION PHARMACEUTICALS INC
- Sold, on record
- $2.6M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Feb 28, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ALEXION PHARMACEUTICALS INCEVP, Chief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedSep 6, 2016 2016
Sold 1,000 shares at $125.94 ($126k)
Thiel Carsten, EVP, Chief Commercial Officer
Sold 2.4% of holdings ($5.2M position)40,579 shares left2x usual sizeFiling
- 2 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualSep 13, 2016 +7 days
Sold 3,225 shares at $128.67 ($415k)
Thiel Carsten, EVP, Chief Commercial Officer
Sold 7.9% of holdings ($5.2M position)37,354 shares left4x usual sizeFiling
- 3 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedOct 3, 2016 +20 days
Sold 29 shares at $122.41 ($4k)
Thiel Carsten, EVP, Chief Commercial Officer
Sold 0.1% of holdings ($4.6M position)37,325 shares left0x usual sizeFiling
- 4 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualOct 14, 2016 +11 days
Sold 4,584 shares at $120.28 ($551k)
Thiel Carsten, EVP, Chief Commercial Officer
Sold 12.3% of holdings ($4.5M position)32,741 shares left5.6x usual sizeFiling
- 5 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedDec 9, 2016 +56 days
Sold 2,308 shares at $130.00 ($300k)
Thiel Carsten, EVP, Chief Commercial Officer
Sold 7% of holdings ($4.3M position)30,433 shares left2.5x usual sizeFiling
- 6 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedFeb 6, 2017 +59 days
Sold 165 shares at $125.69 ($21k)
Thiel Carsten, EVP, Chief Commercial Officer
Sold 0.5% of holdings ($3.8M position)30,268 shares left0.2x usual sizeFiling
- 7 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedFeb 28, 2017 +22 days
Sold 125 shares at $74.52 ($9k)
Thiel Carsten, EVP, Chief Commercial Officer
Sold 0.4% of holdings ($2.3M position)30,143 shares left0.1x usual sizeFiling
- 8 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualFeb 28, 2017 same day
Sold 3,783 shares at $131.01 ($496k)
Thiel Carsten, EVP, Chief Commercial Officer
Sold 10% of holdings ($4.9M position)33,860 shares left4.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2017 | Mar 6, 2017 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 3,783 | $496k | 10.0% | Unusual | SEC |
| Feb 28, 2017 | Mar 1, 2017 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 125 | $9k | 0.4% | Plan not stated | SEC |
| Feb 6, 2017 | Feb 8, 2017 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 165 | $21k | 0.5% | Plan not stated | SEC |
| Dec 9, 2016 | Dec 13, 2016 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 2,308 | $300k | 7.0% | Plan not stated | SEC |
| Oct 14, 2016 | Oct 18, 2016 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 4,584 | $551k | 12.3% | Unusual | SEC |
| Oct 3, 2016 | Oct 5, 2016 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 29 | $4k | 0.1% | Plan not stated | SEC |
| Sep 13, 2016 | Sep 14, 2016 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 3,225 | $415k | 7.9% | Unusual | SEC |
| Sep 6, 2016 | Sep 8, 2016 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 1,000 | $126k | 2.4% | Plan not stated | SEC |
| Feb 29, 2016 | Mar 1, 2016 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 54 | $8k | 0.1% | Plan not stated | SEC |
| Feb 16, 2016 | Feb 18, 2016 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 187 | $27k | 0.5% | Plan not stated | SEC |
| Nov 10, 2015 | Nov 12, 2015 | ALEXION PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Form 4 sale | 3,000 | $520k | 9.7% | Plan not stated | SEC |
| Sep 10, 2015 | Sep 10, 2015 | ALEXION PHARMACEUTICALS INC | SVP, EMEA & Asia Pacific | Form 4 sale | 812 | $137k | 2.7% | Plan not stated | SEC |